Nystatin/Neomycin Sulfate/Thiostrepton/Triamcinolone Acetonide
14 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
14
Total Reports
2
Deaths Reported
1430.0%
Death Rate
Active Ingredients
Nystatin/Neomycin Sulfate/Thiostrepton/Triamcinolone Acetonide
Administration Routes
TopicalUnknown
Species Affected
Cat 8
Dog 6
Most Affected Breeds
Domestic Shorthair 5
Siamese 3
Pinscher - Miniature 1
Dog (unknown) 1
Poodle - Toy 1
Spaniel - Cocker American 1
Whippet 1
Boxer (German Boxer) 1
Most Reported Reactions
Application site alopecia 5
Vomiting 5
Lethargy (see also Central nervous system depression in 'Neurological') 4
Application site erythema 4
Application site burn 3
Application site pruritus 3
Head tilt - ear disorder 3
Pruritus 3
Skin lesion NOS 2
Application site dermatitis 2
Application site bleeding 2
Application site mucopurulent discharge 2
Outcome Breakdown
Outcome Unknown
9 (64.3%)
Recovered/Normal
3 (21.4%)
Euthanized
2 (14.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.